The chemical reactions and pathways resulting in the breakdown of cyclic GMP, guanosine 3',5'-phosphate.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.

Any process that modulates the extent of heart contraction, changing the force with which blood is propelled.

Any process that activates or increases the frequency, rate, or extent of a chronic inflammatory response.

The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.

The memory process that deals with the storage, retrieval and modification of information received a short time (up to about 30 minutes) ago. This type of memory is typically dependent on direct, transient effects of second messenger activation.

Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving cGMP.

Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.

Any process that stops, prevents or reduces the rate or extent of T cell proliferation.

An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure.

Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.

Any process that activates or increases the frequency, rate or extent of MAP kinase activity.

Any process that activates or increases the frequency, rate or extent of G-protein coupled receptor protein signaling pathway activity.

Any process that activates or increases the frequency, rate or extent of vasoconstriction.

The chemical reactions and pathways involving cyclic GMP, guanosine 3',5'-phosphate.

The chemical reactions and pathways resulting in the breakdown of cyclic GMP, guanosine 3',5'-phosphate.

The chemical reactions and pathways resulting in the breakdown of cyclic GMP, guanosine 3',5'-phosphate.

Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle contraction.

The process in which the extent of cardiac muscle contraction is reduced.

Any process that increases the rate or extent of the process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.

Any process that increases the rate or extent of the process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.